How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans

Annual Review of Microbiology

Volumn 63, Issue , 2009, Pages 223-247

  Doering, Tamara Lea ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptococcosis; Fungal virulence; Glycan biosynthesis; Glycosyltransferase

Indexed keywords

CARBOHYDRATE; CELL MEMBRANE PROTEIN; CHITIN; CHITOSAN; GLUCAN; POLYMER; POLYSACCHARIDE;

BIOGENESIS; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CELL WALL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; ENZYMOLOGY; GLYCOSYLATION; HUMAN; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CELL WALL; CRYPTOCOCCUS NEOFORMANS; HUMANS; MODELS, BIOLOGICAL; POLYSACCHARIDES; VIRULENCE;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 67650635524     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.62.081307.162753     Document Type: Review

References (162)

1. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, et al. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338 (Pubitemid 27467536)
2. Ankel H, Ankel E, Feingold DS. 1966. Biosynthesis of uridine diphosphate D-xylose. 3. Uridine diphosphate D-glucose dehydrogenase of Cryptococcus neoformans. Biochemistry 5:1864-1869
3. Ankel H, Feingold DS. 1966. Biosynthesis of uridine diphosphate D-xylose. II. Uridine diphosphate D-glucuronate carboxy-lyase of Cryptococcus laurentii. Biochemistry 5:182-189
4. Bacic A. 2006. Breaking an impasse in pectin biosynthesis. Proc. Natl. Acad. Sci. USA 103:5639-5640
5. Baker LG, Specht CA, Donlin MJ, Lodge JK. 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6:855-867
6. Banks IR, Specht CA, Donlin MJ, Gerik KJ, Levitz SM, Lodge JK. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912
7. Bar-Peled M, Griffith CL, Doering TL. 2001. Functional cloning and characterization of a UDPglucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc. Natl. Acad. Sci. USA 98:12003-12008 (Pubitemid 32959816)
8. Bar-Peled M, Griffith CL, Ory JJ, Doering TL. 2004. Biosynthesis of UDP-GlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans. Biochem. J. 381:131-136 (Pubitemid 38932219)
9. Barreto-Bergter E, Pinto MR, Rodrigues ML. 2004. Structure and biological functions of fungal cerebrosides. An. Acad. Bras. Cienc. 76:67-84 (Pubitemid 38260286)
10. Bartizal K, Gill CJ, Abruzzo GK, Flattery AM, Kong L, et al. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743872). Antimicrob. Agents Chemother. 41:2326-2332 (Pubitemid 27467535)
11. Belay T, Cherniak R, Kozel TR, Casadevall A. 1997. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect. Immun. 65:718-728 (Pubitemid 27053245)
12. Beverley SM, Owens KL, Showalter M, Griffith CL, Doering TL, et al. 2005. Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens. Eukaryot. Cell 4:1147-1154 (Pubitemid 40817473)
13. Bhattacharjee AK, Bennett JE, Glaudemans CP. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624
14. Biondo C, Messina L, Bombaci M, Mancuso G, Midiri A, et al. 2005. Characterization of two novel cryptococcal mannoproteins recognized by immune sera. Infect. Immun. 73:7348-7355 (Pubitemid 41587636)
15. Bose I, Reese AJ, Ory JJ, Janbon G, Doering TL. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2:655-663 (Pubitemid 36996711)
16. Botts MR, Giles SS, Gates MA, Kozel TR, Hull CM. 2009. Isolation and characterization of Cryptococcus neoformans spores reveals a critical role for capsule biosynthesis genes in spore biogenesis. Eukaryot. Cell 8:595-605
17. Bovers M, Hagen F, Boekhout T. 2008. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev. Iberoam. Micol. 25:S4-12
18. Bryan RA, Zaragoza O, Zhang T, Ortiz G, Casadevall A, Dadachova E. 2005. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot. Cell 4:465-475 (Pubitemid 40257145)
19. Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B. 2009. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 37:D233-38
20. Castle SA, Owuor EA, Thompson SH, Garnsey MR, Klutts JS, et al. 2008. Beta1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids. Eukaryot. Cell 7:1611-1615
21. Chaka W, Verheul AF, Vaishnav VV, Cherniak R, Scharringa J, et al. 1997. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect. Immun. 65:272-278 (Pubitemid 27008933)
22. Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ. 2006. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect. Immun. 74:3930-3938 (Pubitemid 43993325)
23. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell Biol. 14:4912-4919
24. Chang YC, Kwon-Chung KJ. 1998. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:2230-2236
25. Chang YC, Kwon-Chung KJ. 1999. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J. Bacteriol. 181:5636-5643 (Pubitemid 29437133)
26. Chang YC, Penoyer LA, Kwon-Chung KJ. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983 (Pubitemid 26165655)
27. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am. J. Pathol. 166:421-432 (Pubitemid 40189039)
28. Chayakulkeeree M, Perfect JR. 2006. Cryptococcosis. Infect. Dis. Clin. North Am. 20:507-544
29. Chayakulkeeree M, Sorrell TC, Siafakas AR, Wilson CF, Pantarat N, et al. 2008. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol. Microbiol. 69:809-826 (Pubitemid 352033304)
30. Cherniak R, Morris LC, Belay T, Spitzer ED, Casadevall A. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1899-1905
31. Cherniak R, Reiss E, Slodki ME, Plattner RD, Blumer SO. 1980. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol. Immunol. 17:1025-1032 (Pubitemid 10087383)
32. Cherniak R, Sundstrom JB. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512 (Pubitemid 24136940)
33. Cherniak R, Valafar H, Morris LC, Valafar F. 1998. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab. Immunol. 5:146-159 (Pubitemid 28161182)
34. Cleare W, Casadevall A. 1999. Scanning electron microscopy of encapsulated and nonencapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med. Mycol. 37:235-243 (Pubitemid 29364139)
35. Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, et al. 2002. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin. Infect. Dis. 34:1251-1258 (Pubitemid 34450674)
36. Cottrell TR, Griffith CL, Liu H, Nenninger AA, Doering TL. 2007. The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot. Cell 6:776-785 (Pubitemid 46835041)
37. Cowen LE, Steinbach WJ. 2008. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot. Cell 7:747-764
38. Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA. 2006. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot. Cell 5:1147-1156
39. De Groot PW, Ram AF, Klis FM. 2005. Features and functions of covalently linked proteins in fungal cell walls. Fungal Genet. Biol. 42:657-675
40. De Jesus M, Nicola AM, Rodrigues ML, Janbon G, Casadevall A. 2009. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot. Cell 8:96-103
41. Del Poeta M. 2004. Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot. Cell 3:1067-1075 (Pubitemid 39385214)
42. Doering TL. 2000. How does Cryptococcus get its coat? Trends Microbiol. 8:547-553
43. Dong ZM, Murphy JW. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65:557-563
44. Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752 (Pubitemid 17021971)
45. Eigenheer RA, Jin Lee Y, Blumwald E, Phinney BS, Gelli A. 2007. Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans. FEMS Yeast Res. 7:499-510 (Pubitemid 46788671)
46. Ellerbroek PM, Walenkamp AM, Hoepelman AI, Coenjaerts FE. 2004. Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr. Med. Chem. 11:253-266
47. Fader CM, Colombo MI. 2009. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 16:70-78
48. Falkow S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2):S274-76
49. Feldmesser M, Kress Y, Casadevall A. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiol. 147:2355-2365 (Pubitemid 32785515)
50. Franzot SP, Doering TL. 1999. Inositol acylation of glycosylphosphatidylinositols in the pathogenic fungus Cryptococcus neoformans and the model yeast Saccharomyces cerevisiae. Biochem. J. 340(Pt. 1):25-32
51. Franzot SP, Mukherjee J, Cherniak R, Chen L-C, Hamdan JS, Casadevall A. 1998. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect. Immun. 66:89-97 (Pubitemid 28018806)
52. Franzot SP, Salkin IF, Casadevall A. 1999. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J. Clin. Microbiol. 37:838-840 (Pubitemid 29091323)
53. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7:319-327 (Pubitemid 351959699)
54. French N, Gray K, Watera C, Nakiyingi J, Lugada E, et al. 2002. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. Aids 16:1031-1038 (Pubitemid 34499426)
55. Fromtling RA, Shadomy HJ, Jacobson ES. 1982. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79:23-29 (Pubitemid 13227139)
56. Garcia-Hermoso D, Dromer F, Janbon G. 2004. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72:3359-3365 (Pubitemid 38697760)
57. Garcia-Hermoso D, Janbon G, Dromer F. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J. Clin. Microbiol. 37:3204-3209 (Pubitemid 29455206)
58. Gates MA, Kozel TR. 2006. Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans. Infect. Immun. 74:3096-3106
59. Gates MA, Thorkildson P, Kozel TR. 2004. Molecular architecture of the Cryptococcus neoformans capsule. Mol. Microbiol. 52:13-24 (Pubitemid 38519618)
60. Gemmill TR, Trimble RB. 1999. Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim. Biophys. Acta 1426:227-238
61. Gerik KJ, Bhimireddy SR, Ryerse JS, Specht CA, Lodge JK. 2008. PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 7:1685-1698
62. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, et al. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66
63. Gomez BL, Nosanchuk JD. 2003. Melanin and fungi. Curr. Opin. Infect. Dis. 16:91-96
64. Gonzales M, Lipke PN, Ovalle R. 2009. Glycosylphosphatidylinositol (GPI) anchoring of proteins. In The Enzymes, ed. AK Menon, T Kinoshita, P Orlean, F Tamanoi, 26:299-334. San Diego, CA: Academic
65. Gonzalez M, de Groot PWJ, Klis FM, Lipke PN. 2009. Glycoconjugate structure and function in fungal cell walls. In Microbial Glycobiology: Structures, Relevance, and Applications, ed. A Moran, P Brennan, O Holst, M von Itzstein. San Diego, CA: Elsevier. In press
66. Griffith CL, Klutts JS, Zhang L, Levery SB, Doering TL. 2004. UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J. Biol. Chem. 279:51669-51676 (Pubitemid 40017918)
67. Grun CH, Hochstenbach F, Humbel BM, Verkleij AJ, Sietsma JH, et al. 2005. The structure of cell wall alpha-glucan from fission yeast. Glycobiology 15:245-257 (Pubitemid 40347351)
68. Hedges SB, Blair JE, Venturi ML, Shoe JL. 2004. A molecular timescale of eukaryote evolution and the rise of complex multicellular life. BMC Evol. Biol. 4:2
69. Heiss C, Klutts JS, Wang Z, Doering TL, Azadi P. 2009. The Structure of Cryptococcus neoformans galactoxylomannan contains β-D-glucuronic acid. Carbohydr. Res. 344:915-920
70. Hu G, Liu I, Sham A, Stajich JE, Dietrich FS, Kronstad JW. 2008. Comparative hybridization reveals extensive genome variation in the AIDS-associated pathogen Cryptococcus neoformans. Genome Biol. 9:R41 (Pubitemid 351943988)
71. Ikeda R, Nishikawa A, Shinoda T, Fukazawa Y. 1985. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol. Immunol. 29:981-991 (Pubitemid 16257513)
72. Iwase H. 1988. Variety and microheterogeneity in the carbohydrate chains of glycoproteins. Int. J. Biochem. 20:479-491 (Pubitemid 18108677)
73. Jacobson ES, Ikeda R. 2005. Effect of melanization upon porosity of the cryptococcal cell wall. Med. Mycol. 43:327-333 (Pubitemid 41030459)
74. Jacobson ES, Payne WR. 1982. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J. Bacteriol. 152:932-934
75. Jacobson ES, Tingler MJ. 1994. Strains of Cryptococcus neoformans with defined capsular phenotypes. J. Med. Vet. Mycol. 32:401-404
76. Jain N, Fries BC. 2008. Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii. Mycopathologia 166:181-188
77. James PG, Cherniak R. 1992. Galactoxylomannans of Cryptococcus neoformans. Infect. Immun. 60:1084-1088
78. James PG, Cherniak R, Jones RG, Stortz CA. 1998. Cell-wall glucans of Cryptococcus neoformans CAP67. Carbohyd. Res. 198:23-28
79. Janbon G, Himmelreich U, Moyrand F, Improvisi L, Dromer F. 2001. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol. Microbiol. 42:453-467 (Pubitemid 32990133)
80. Jong A, Wu CH, Chen HM, Luo F, Kwon-Chung KJ, et al. 2007. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 6:1486-1496 (Pubitemid 47257717)
81. Kartsonis NA, Nielsen J, Douglas CM. 2003. Caspofungin: the first in a new class of antifungal agents. Drug Resist. Updat. 6:197-218 (Pubitemid 37129919)
82. Klis FM, Boorsma A, De Groot PW. 2006. Cell wall construction in Saccharomyces cerevisiae. Yeast 23:185-202
83. Klutts JS, Doering TL. 2008. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J. Biol. Chem. 283:14327-14334
84. Klutts JS, Levery SB, Doering TL. 2007. A beta-1,2 xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases. J. Biol. Chem. 282:17890-17899
85. Klutts JS, Yoneda A, Reilly MC, Bose I, Doering TL. 2006. Glycosyltransferases and their products: cryptococcal variations on fungal themes. FEMS Yeast Res. 6:499-512 (Pubitemid 43725734)
86. Kozel TR, Levitz SM, Dromer F, Gates MA, Thorkildson P, Janbon G. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect. Immun. 71:2868-2875 (Pubitemid 36519900)
87. Kraus PR, Fox DS, Cox GM, Heitman J. 2003. The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol. Microbiol. 48:1377-1387 (Pubitemid 36718230)
88. Kwon-Chung KJ, Varma A. 2006. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 6:574-587
89. Lesage G, Bussey H. 2006. Cell wall assembly in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 70:317-343 (Pubitemid 43895030)
90. Levitz SM, Nong S, Mansour MK, Huang C, Specht CA. 2001. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 98:10422-10427 (Pubitemid 32803035)
91. Levitz SM, Specht CA. 2006. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 6:513-524 (Pubitemid 43725735)
92. Lin X, Heitman J. 2006. The biology of the Cryptococcus neoformans species complex. Annu. Rev. Microbiol. 60:69-105 (Pubitemid 44627941)
93. Liu OW, Kelly MJ, Chow ED, Madhani HD. 2007. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Eukaryot. Cell 6:630-640
94. Loftus BJ, Fung E, Roncaglia P, Rowley D, Amedeo P, et al. 2005. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307:1321-1324 (Pubitemid 40299983)
95. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, et al. 2006. Long-term outcome of AIDSassociated cryptococcosis in the era of combination antiretroviral therapy. AIDS 20:2183-2191 (Pubitemid 44684709)
96. Maligie MA, Selitrennikoff CP. 2005. Cryptococcus neoformans resistance to echinocandins: (1,3)betaglucan synthase activity is sensitive to echinocandins. Antimicrob. Agents Chemother. 49:2851-2856
97. Maxson ME, Dadachova E, Casadevall A, Zaragoza O. 2007. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot. Cell 6:95-109 (Pubitemid 46147656)
98. McFadden D, Zaragoza O, Casadevall A. 2006. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 14:497-505
99. McFadden DC, De Jesus M, Casadevall A. 2006. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J. Biol. Chem. 281:1868-1875 (Pubitemid 43845771)
100. McFadden DC, Fries BC, Wang F, Casadevall A. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6:1464-1473 (Pubitemid 47257715)
101. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, et al. 2003. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin. Infect. Dis. 36:789-794 (Pubitemid 36337986)
102. Monari C, Bistoni F, Casadevall A, Pericolini E, Pietrella D, et al. 2005. Glucuronoxylomannan, microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J. Infect. Dis. 191:127-137 (Pubitemid 40041411)
103. Monari C, Bistoni F, Vecchiarelli A. 2006. Glucuronoxylomannan exhibits potent immunosuppressive properties. FEMS Yeast Res. 6:537-542 (Pubitemid 43725737)
104. Moyrand F, Chang YC, Himmelreich U, Kwon-Chung KJ, Janbon G. 2004. Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot. Cell 3:1513-1524 (Pubitemid 40025109)
105. Moyrand F, Fontaine T, Janbon G. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64:771-781 (Pubitemid 46653216)
106. Moyrand F, Janbon G. 2004. UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37°-C and for capsule biosynthesis. Eukaryot. Cell 3:1601-1608 (Pubitemid 40025117)
107. Moyrand F, Klaproth B, Himmelreich U, Dromer F, Janbon G. 2002. Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol. Microbiol. 45:837-849 (Pubitemid 34989189)
108. Moyrand F, Lafontaine I, Fontaine T, Janbon G. 2008. UGE1 and IGE2 regulated the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans. Eukaryot. Cell 7:2069-2077
109. Mukherjee J, Scharff MD, Casadevall A. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541
110. Nickel W. 2003. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270:2109-2119 (Pubitemid 36608925)
111. Nimrichter L, Frases S, Cinelli LP, Viana NB, Nakouzi A, et al. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot. Cell 6:1400-1410 (Pubitemid 47257709)
112. Olson GM, Fox DS, Wang P, Alspaugh JA, Buchanan KL. 2007. Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans. Eukaryot. Cell 6:222-234 (Pubitemid 46303289)
113. Palmer GE, Askew DS, Williamson PR. 2008. The diverse roles of autophagy in medically important fungi. Autophagy 4:982-988
114. Panepinto J, Liu L, Ramos J, Zhu X, Valyi-Nagy T, et al. 2005. The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans. J. Clin. Invest. 115:632-641 (Pubitemid 40322237)
115. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the global burden of cryptcoccal meningitis among persons living with HIV/AIDS. AIDS 23:525-530
116. Perfect JR. 2005. Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol. Med. Microbiol. 45:395-404 (Pubitemid 41258130)
117. Perfect JR. 2007. Management of cryptococcosis: How are we doing? PLOS Med. 4:232-233
118. Pericolini E, Cenci E, Monari C, De Jesus M, Bistoni F, et al. 2006. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell Microbiol. 8:267-275 (Pubitemid 43356049)
119. Pierini LM, Doering TL. 2001. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol. Microbiol. 41:105-115
120. Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, et al. 2007. An antibeta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect. Immun. 75:5085-5094 (Pubitemid 350033595)
121. Reese AJ, Doering TL. 2003. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409
122. Reese AJ, Yoneda A, Breger JA, Beauvais A, Liu H, et al. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63:1385-1398 (Pubitemid 46257157)
123. Reilly MC, Doering TL. 2009. Biosynthesis of fungal and yeast glycans. In Microbial Glycobiology: Structures, Relevance, and Applications, ed. A Moran, P Brennan, O Holst, M von Itzstein. San Diego, CA: Elsevier. In press
124. Rhome R, McQuiston T, Kechichian T, Bielawska A, Hennig M, et al. 2007. Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens. Eukaryot. Cell 6:1715-1726 (Pubitemid 47592097)
125. Rivera J, Feldmesser M, Cammer M, Casadevall A. 1998. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun. 66:5027-5030 (Pubitemid 28453116)
126. Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. 2008. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot. Cell 7:602-609 (Pubitemid 351959894)
127. Rodrigues ML, Dobroff AS, Couceiro JN, Alviano CS, Schauer R, Travassos LR. 2003. Sialylglycoconjugates and sialyltransferase activity in the fungus Cryptococcus neoformans. Glycoconj. J. 19:165-173
128. Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, et al. 2008. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 7:58-67 (Pubitemid 351959594)
129. Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, et al. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot. Cell 6:48-59 (Pubitemid 46147652)
130. Saha DC, Goldman DL, Shao X, Casadevall A, Husain S, et al. 2007. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin. Vaccine Immunol. 14:1550-1554
131. Sakaguchi N, Baba T, Fukuzawa M, Ohno S. 1993. Ultrastructural study of Cryptococcus neoformans by quick-freezing and deep-etching method. Mycopathologia 121:133-141
132. Samuelson J, Banerjee S, Magnelli P, Cui J, Kelleher DJ, et al. 2005. The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc. Natl. Acad. Sci. USA 102:1548-1553 (Pubitemid 40209206)
133. Schutzbach J, Ankel H, Brockhausen I. 2007. Synthesis of cell envelope glycoproteins of Cryptococcus laurentii. Carbohydr. Res. 342:881-893 (Pubitemid 46385907)
134. Shahinian S, Bussey H. 2000. Beta-1,6-glucan synthesis in Saccharomyces cerevisiae. Mol. Microbiol. 35:477-489
135. Siafakas AR, Sorrell TC, Wright LC, Wilson C, Larsen M, et al. 2007. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J. Biol. Chem. 282:37508-37514
136. Sommer U, Liu H, Doering TL. 2003. An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J. Biol. Chem. 278:47724-47730
137. Steenbergen JN, Casadevall A. 2003. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 5:667-675 (Pubitemid 36645127)
138. Takeo K, Uesaka I, Uehira K, Nihiura M. 1973. Fine structure of Cryptococcus neoformans grown in vitro as observed by freeze-etching. J. Bacteriol. 113:1442-1448
139. Takeo K, Uesaka I, Uehira K, Nihiura M. 1973. Fine structure of Cryptococcus neoformans grown in vivo as observed by freeze-etching. J. Bacteriol. 113:1449-1454
140. Tangen KL, Jung WH, Sham AP, Lian T, Kronstad JW. 2007. The iron- and cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in Cryptococcus neoformans. Microbiology 153:29-41 (Pubitemid 46115660)
141. Thery C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2:569-579
142. Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, et al. 1999. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J. Bacteriol. 181:444-453 (Pubitemid 29045134)
143. Turner KM, Wright LC, Sorrell TC, Djordjevic JT. 2006. N-linked glycosylation sites affect secretion of cryptococcal phospholipase B1, irrespective of glycosylphosphatidylinositol anchoring. Biochim. Biophys. Acta 1760:1569-1579
144. Turner SH, Cherniak R, Reiss E. 1984. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr. Res. 125:343-349
145. Vaishnav VV, Bacon BE, O'Neill M, Cherniak R. 1998. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr. Res. 306:315-330 (Pubitemid 28305000)
146. van de Moer A, Salhi SL, Cherniak R, Pau B, Garrigues ML, Bastide JM. 1990. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res. Immunol. 141:33-42 (Pubitemid 20140512)
147. Vartivarian SE, Reyes GH, Jacobson ES, James PG, Cherniak R, et al. 1989. Localization of mannoprotein in Cryptococcus neoformans. J. Bacteriol. 171:6850-6852
148. White CW, Cherniak R, Jacobson ES. 1990. Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans. J. Med. Vet. Mycol. 28:289-301 (Pubitemid 20387365)
149. White CW, Jacobson ES. 1993. Mannosyl transfer in Cryptococcus neoformans. Can. J. Microbiol. 39:129-133
150. Willer T, Valero MC, Tanner W, Cruces J, Strahl S. 2003. O-mannosyl glycans: from yeast to novel associations with human disease. Curr. Opin. Struct. Biol. 13:621-630 (Pubitemid 37247604)
151. Williamson PR. 1997. Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front. Biosci. 2:e99-107
152. Wills EA, Roberts IS, del Poeta M, Rivera J, Casadevall A, et al. 2001. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol. Microbiol. 40:610-620 (Pubitemid 32453114)
153. Wozniak KL, Levitz SM. 2009. Isolation and purification of antigenic components of Cryptococcus. Methods Mol. Biol. 470:71-83
154. Xu J, Vilgalys R, Mitchell TG. 2000. Multiple gene genealogies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans. Mol. Ecol. 9:1471-1481
155. Yamaguchi M, Biswas SK, Kita S, Aikawa E, Takeo K. 2002. Electron microscopy of pathogenic yeasts Cryptococcus neoformans and Exophiala dermatitidis by high-pressure freezing. J. Electron. Microsc. 51:21-27 (Pubitemid 34293942)
156. Yin QY, de Groot PW, de Koster CG, Klis FM. 2008. Mass spectrometry-based proteomics of fungal wall glycoproteins. Trends Microbiol. 16:20-26
157. Yoneda A, Doering TL. 2006. A eukaryotic capsular polysaccharide is
158. Yoneda A, Doering TL. 2008. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot. Cell 7:546-549 (Pubitemid 351959683)
159. Young AC, Valadon P, Casadevall A, Scharff MD, Sacchettini JC. 1997. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J. Mol. Biol. 274:622-634 (Pubitemid 28004673)
160. Zaragoza O, Casadevall A. 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proc. Online 6:10-15 (Pubitemid 38597697)
161. Zaragoza O, Taborda CP, Casadevall A. 2003. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur. J. Immunol. 33:1957-1967 (Pubitemid 37120868)
162. Zaragoza O, Telzak A, Bryan RA, Dadachova E, Casadevall A. 2006. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol. Microbiol. 59:67-83